Variant report
Variant | nsv962057 |
---|---|
Chromosome Location | chr2:7406316-7411184 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:7410454..7413137-chr2:7415819..7418028,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143781878 | chr2:7406332-7406333 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187976929 | chr2:7406356-7406357 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs768447 | chr2:7406365-7406366 | Weak transcription Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs192012352 | chr2:7406416-7406417 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565878048 | chr2:7406432-7406433 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534198256 | chr2:7406452-7406453 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs553026021 | chr2:7406509-7406510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs547818023 | chr2:7406522-7406523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184568032 | chr2:7406550-7406551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs377469597 | chr2:7406556-7406557 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs35773457 | chr2:7406581-7406582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs536762899 | chr2:7406610-7406611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141335369 | chr2:7406624-7406625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576560994 | chr2:7406647-7406648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557257408 | chr2:7406672-7406673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538902880 | chr2:7406678-7406679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145061605 | chr2:7406693-7406694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138843526 | chr2:7406705-7406706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540583280 | chr2:7406717-7406718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186991283 | chr2:7406737-7406738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs574167999 | chr2:7406756-7406757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12472309 | chr2:7406826-7406827 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs78821236 | chr2:7406881-7406882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532328354 | chr2:7406908-7406909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs16866047 | chr2:7406913-7406914 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs559555304 | chr2:7406929-7406930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs528407676 | chr2:7406947-7406948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs17629193 | chr2:7406992-7406993 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs567641591 | chr2:7406993-7406994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536676371 | chr2:7407013-7407014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs12473129 | chr2:7407038-7407039 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs184314531 | chr2:7407061-7407062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs12692333 | chr2:7407069-7407070 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs558893146 | chr2:7407094-7407095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs141957635 | chr2:7407106-7407107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535008211 | chr2:7407111-7407112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554872679 | chr2:7407132-7407133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574080037 | chr2:7407136-7407137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543056513 | chr2:7407153-7407154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557018511 | chr2:7407155-7407156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150823372 | chr2:7407164-7407165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs545945391 | chr2:7407282-7407283 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559302890 | chr2:7407301-7407302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs375682851 | chr2:7407324-7407325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542127876 | chr2:7407334-7407335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs562001065 | chr2:7407342-7407343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs530112482 | chr2:7407382-7407383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189598074 | chr2:7407413-7407414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182012381 | chr2:7407426-7407427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570091557 | chr2:7407433-7407434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17133270 | CNVD |
Mental retardation | 17847001 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Cancer | 20164920 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 16751803 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ependymoma | 16718352 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Glioma | 17123091 | CNVD |
Breast cancer | 20409316 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:7400200-7410000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr2:7400200-7428600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
3 | chr2:7404000-7414200 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr2:7404800-7406600 | Enhancers | Fetal Brain Male | brain |
5 | chr2:7405400-7410200 | Weak transcription | Fetal Brain Female | brain |
6 | chr2:7406200-7406400 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr2:7406600-7407600 | Weak transcription | Fetal Brain Male | brain |
8 | chr2:7407600-7408200 | Enhancers | Fetal Brain Male | brain |
9 | chr2:7408000-7408600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr2:7408000-7408600 | Enhancers | Fetal Stomach | stomach |
11 | chr2:7408200-7410000 | Weak transcription | Fetal Brain Male | brain |
12 | chr2:7408400-7408600 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
13 | chr2:7410000-7410200 | Enhancers | Fetal Brain Male | brain |
14 | chr2:7410000-7410400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr2:7410000-7410400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
16 | chr2:7410000-7410600 | Enhancers | Fetal Muscle Trunk | muscle |
17 | chr2:7410200-7410600 | Enhancers | Fetal Brain Female | brain |